Understanding the Impact and Consequences of Hallucinations and Delusions Associated With Dementia-Related Psychosis


Perspectives From a Neurologist, Geriatric Psychiatrist, and Caregiver
In recognition of World Alzheimer's Month, this broadcast is intended to raise awareness among healthcare professionals and caregivers regarding hallucinations and delusions associated with dementia-related psychosis, including the need for earlier identification and diagnosis.
Meet the Speakers

Alireza Atri, MD, PhD
Director
Banner Sun Health Research Institute
Sun City, AZ

Davangere P. Devanand, MBBS, MD
Director, Geriatric Psychiatry
Professor of Psychiatry and Neurology
Department of Psychiatry
Columbia University Medical Center
New York, NY

Linda Gregory
Caregiver to her mother, who is living with Alzheimer’s disease dementia and experiencing hallucinations and delusions associated with dementia-related psychosis.
Paid consultants of Acadia Pharmaceuticals Inc.
The objectives of the broadcast are to:
Educate on the patient and caregiver burden of hallucinations and delusions associated with dementia-related psychosis
Explore the unmet needs in the diagnosis and management of dementia-related hallucinations and delusions
Enhance the dialogue between healthcare professionals and caregivers about hallucinations and delusions associated with dementia-related psychosis to help improve earlier identification and diagnosis of these symptoms
This disease-awareness, non-CME program is intended only for healthcare professionals involved in the management of people with dementia-related hallucinations and delusions and is sponsored by Acadia Pharmaceuticals Inc.
©2020 Acadia Pharmaceuticals Inc. Acadia is a registered trademark of Acadia Pharmaceuticals Inc. All rights reserved. DRP-0264 09/20
This website is intended for US healthcare professionals only.
